ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

DC Board Okay One Recompetition, Disapproves Two

November 12, 1982

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

ACCP Publishes Guidelines Recommending Low-Dose CT

May 31, 2013

Denosumab Demonstrates Superiority Over Zometa For Bone Metastases

August 28, 2009

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005